The information provided by our users and Health Authorities allows us to assess the benefits of our products and their potential risks, help us to continuously improve their quality, performance, handling and, above all, their safety, throughout the lifetime of our medical devices.
The Clinical Evaluation and Post Market Surveillance (PMS) are key activities coordinated by our Medical Affairs Department to systematically gather, record, and analyze safety and performance information, on our products, received from the market. After proper and careful planning of the data collection from proactive and reactive sources, following a strict schedule, the PMS Reports have the record of all the activities conducted, displaying the results of the data collected, and information on any corrective and preventive actions that have been implemented.
We, at Macopharma Medical Affairs Department, consider that the highest level of performance and safety of our products is not enough. We strive to purvey only the excellence to our patients.